Albanese says PBS medicine co-payment cap will stay at $25 until 2030
Published · Updated
What happened
Anthony Albanese announced that the maximum cost of Pharmaceutical Benefits Scheme medicines will remain at $25 until 2030.
Why it matters
The announcement extends a visible household-cost setting in a policy area with direct voter salience. It also commits the government to carrying the fiscal and implementation burden of maintaining the cap over multiple years.
Prime Minister Anthony Albanese announced on 2026-11-23 that the maximum patient cost for medicines under the Pharmaceutical Benefits Scheme will remain at $25 until 2030. The government framed the measure as cost-of-living relief and timed it for the final parliamentary week, giving Labor an immediate household-economics message. The announcement matters politically because it offers a concrete retail policy claim ahead of recess, but it also creates a follow-through test on funding, legislation, and coalition management.
Watch for
Department of Health and Aged Care publication on 2026-11-24 or 2026-11-25 setting out implementation details or funding assumptions for the PBS $25 cap extension House of Representatives program or government business notice on 2026-11-24 or 2026-11-25 listing any bill or appropriation linked to the PBS co-payment measure Opposition Leader statement by 2026-11-25 confirming support, amendment demands, or costings attack on the PBS $25 cap Prime Minister Anthony Albanese or Treasurer statement by 2026-11-25 specifying whether the measure is funded in MYEFO, a new appropriation, or a later budget update
Sources
Researched and written by AI from the sources listed, under published rules. How V³ Aware is made